Skip to main content
All lobbying filings

BUCHANAN INGERSOLL & ROONEY PC

Lobbying for GENERIC ANIMAL DRUG ALLIANCE · Professional trade association for generic animal drug products.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · posted Apr 20, 2026

Official filing document

 Bills named in this filing 2
  • HR 1683
    Protecting Rural Seniors’ Access to Care Act
  • HR 1418
    Purchased and Referred Care Improvement Act of 2025
 Lobbying activity 4
Animals

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Health Issues

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Medical/Disease Research/Clinical Labs

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Pharmacy

Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem